Dr. Jannis Fischer – Trademark Portfolio
Entity Type: 01
Dr. Jannis Fischer holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 5 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include NEUROLF, POSITRIGO, and POSITRIGO IMAGING EVERYONE.
Menzelstraße 9
12157 Berlin
Showing of trademarks Trademarks
Trademark Classifications
Dr. Jannis Fischer's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Dr. Jannis Fischer have?
Dr. Jannis Fischer has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Dr. Jannis Fischer file in?
Dr. Jannis Fischer files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Dr. Jannis Fischer's most well-known trademarks?
Dr. Jannis Fischer's registered trademark portfolio includes well-known marks such as NEUROLF, POSITRIGO, and POSITRIGO IMAGING EVERYONE. These are among 4 currently registered trademarks in the portfolio.
What is Dr. Jannis Fischer's trademark registration success rate?
Dr. Jannis Fischer has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.